Johnson & Johnson completed its acquisition of Shockwave Medical, Inc., a leader in intravascular lithotripsy (IVL) technology, for approximately US$13.1 billion.

Shockwave is now part of Johnson & Johnson and will operate as a business unit within Johnson & Johnson MedTech.

Freshfields Bruckhaus Deringer acted as legal counsel to Johnson & Johnson with a team led by partners Matthew Herman and Valerie Ford Jacob.

Fenwick & West acted as legal counsel to Shockwave with a team led by partners David Michaels and Michael Brown.